{"title": "GLUTATHIONE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews", "author": null, "url": "https://www.webmd.com/vitamins/ai/ingredientmono-717/glutathione", "hostname": "webmd.com", "description": "Learn more about GLUTATHIONE uses, effectiveness, possible side effects, interactions, dosage, user ratings and products that contain GLUTATHIONE.", "sitename": "webmd.com", "date": "2005-01-01", "cleaned_text": "Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011 Sep;17(9):827-33. View abstract. Amano J, Suzuki A, Sunamori M. Salutary effect of reduced glutathione on renal function in coronary artery bypass operation. J Am Coll Surg 1994;179:714-20. View abstract. Amores-Sanchez MI, Medina MA. Glutamine, of glutathione, and oxidative stress. Mol Genet Metab 1999;67:100-5. View and modulation. Chem Biol Interact 1998;24;111-112:1-14. Antioxidant lozenge could help ward off flu. www.reutershealth.com (Accessed 19 April 2000). Aw TY, Wierzbicka G, Jones DP. Oral glutathione increases tissue glutathione Chem 1991;80:89-97. abstract. Bains JS, Shaw CA. Neurodegenerative the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 1997;25:335-58. View abstract. Borok Z, Buhl R, Grimes GJ, et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary View abstract. Bozic M, Goss CH, Tirouvanziam RM, et al. Oral abstract. Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced S, Frontini L, Comella G, et al. Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Dig. Tract Cancer (GISCAD). Br J Cancer 1999;79(3-4):491-4. View abstract. Cascinu S, Labianca R, Alessandroni P, et al. Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol 1997;15:3313-9. View abstract. Ciuchi E, Odetti P, Prando R. The effect of acute glutathione treatment on sorbitol level in erythrocytes from diabetic patients. Diabetes Metab 1997;23:58-60. View abstract. Cook GC, Sherlock S. Results of a controlled clinical trial of glutathione in cases of hepatic cirrhosis. Gut 1965;6:472-6. View abstract. De Mattia G, Bravi MC, Laurenti O, et al. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1998;47:993-7. View abstract. Di Re F, Bohm S, Oriana S, et al. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Ann Oncol 1993;4:55-61. View abstract. Droge W, Holm E. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J 1997;11:1077-89. View abstract. Flagg EW, Coates RJ, Jones DP, et al. Dietary glutathione intake and the risk of oral and pharyngeal cancer. Am J Epidemiol 1994;139:453-65. View abstract. Graziano F, Cardarelli N, Marcellini M, et al. A pilot clinical trial of postoperative intensive weekly chemotherapy using cisplatin, epi-doxorubicin, 5-fluorouracil, 6S-leucovorin, View abstract. Hagen TM, Wierzbicka GT, Bowman BB, et al. Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol 1):G530-5. IA. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. Int J Dermatol 2016;55(2):153-7. View abstract. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 1997;94:1967-72. View abstract. Holroyd R, Borok Z, et al. Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 1993;48:985-9. View abstract. Honda Y, Kessoku T, Sumida Y, et al. Efficacy of glutathione for the treatment of nonalcoholic fatty SY, Gil HW, Yang JO, Lee EY, Kim HK, Kim SH, Chung YH, Hwang SK, Lee ZW. Pharmacokinetics of glutathione and its metabolites in normal subjects. J Korean Med Sci. 2005 Oct;20(5):721-6. View abstract. Hwang P, Morales Marroqu\u00edn FE, Gann J, et al. Eight weeks of resistance training in conjunction with glutathione and L-Citrulline supplementation increases lean mass and has no adverse effects on blood clinical safety markers in resistance-trained males. J Int Soc Sports Nutr 2018;15(1):30. View abstract. Jenner P, Olanow CW. Understanding in Parkinson's disease. Neurol 1998;44(3 Suppl 1):S72-84. View abstract. Oxidative death in Parkinson's disease. Mov Disord 1998;(13 Suppl)1:24-34. View abstract. Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR. A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit. 2011 Dec;17(12):CR677-82. View abstract. Knapen MF, Mulder TP, Van Rooij IA, et al. Low whole blood glutathione levels in pregnancies complicated by preeclampsia or the hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol 1998;92:1012-5. View abstract. Knapen Glutathione and glutathione-related enzymes in placenta of controls and women with pre-eclampsia. Placenta 1999;20:541-6. View abstract. Lai CY, Cheng SB, Lee TY, Hsiao YF, Liu HT, Huang YC. Impact glutathione and vitamin in cirrhosis patients: a randomized controlled trial and follow-up Nutrients. abstract. Lenzi A, Culasso F, Gandini L, Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993;8:1657-62. View abstract. Leone R, Fracasso ME, Soresi E, et al. Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin. Cancer Chemother Pharmacol 1992;29:385-90. View abstract. Links M, Lewis C. Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. Drugs 1999;57:293-308. View abstract. Locatelli MC, D'Antona A, Labianca R, et al. A phase II study of combination chemotherapy in advanced ovarian carcinoma with cisplatin and cyclophosphamide plus reduced glutathione as potential protective agent against cisplatin toxicity. Tumori 1993;79:37-9. View abstract. Loguercio C, Di Pierro M. The role of glutathione in gastrointestinal tract: and disease: pharmacotherapeutic issues. Ann Pharmacother abstract. Lu SC. of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999;13:1169-83. View abstract. Marrades RM, Roca J, Barbera JA, et al. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med 1997;156(2 Pt 1):425-30. View abstract. Marshall KA, Reist M, Jenner P, el al. The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione implications for Parkinson's disease. Radic View abstract. Martin HL, Teismann P. Glutathione--a review on its role and significance in Parkinson's disease. FASEB J. 2009 Oct;23(10):3263-72. View abstract. Merad-Boudia M, Nicole A, Santiard-Baron D, et al. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: J Parkinsons Dis 2017;7(2):289-99. View abstract. Parnis FX, Coleman RE, Harper PG, et al. A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer. Eur J Cancer 1995;31A:1721. View abstract. Pearce RK, Owen A, Daniel S, et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's 1997;104:661-77. View abstract. Plaxe S, Freddo J, Kim S, et al. Phase I trial of cisplatin in combination with glutathione. Gynecol Oncol 1994;55:82-6. View abstract. Powers SK, Hamilton K. Antioxidants and exercise. Clin Sports Med 1999;18:525-36. View abstract. Powers SK, Ji LL, Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports EW, et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998;24:699-704. View abstract. Schmitt B, Vicenzi M, C, Denis FM. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of markers: 2015;6:198-205. View abstract. Sechi G, Deledda MG, Bua G, et al. Reduced intravenous glutathione in the treatment of early Parkinson's Psychiatry 1996;20:1159-70. View Bowman A, Perren T, et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol 1997;8:569-73. View abstract. Usberti M, Lima G, Arisi M, et al. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J Nephrol 1997;10:261-5. View abstract. Wahab S, Anwar AI, Zainuddin AN, Hutabarat EN, Anwar AA, Kurniadi I. Combination of topical and oral glutathione as a skin-whitening agent: a double-blind randomized controlled clinical trial. Int J Dermatol 2021;60(8):1013-1018. View abstract. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993;169:1456-61. View abstract. Wang L, Xu E, Ren S, Gu X, Zheng J, Yang J. Reduced glutathione does not further reduce contrast-induced nephropathy in elderly patients with diabetes receiving percutaneous coronary intervention. J Int Med Res 2020;48(11):300060520964017. View abstract. Witschi A, Reddy S, Stofer B, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992;43:667-9. View abstract. "}